Vical Provides Company Update at Biocom's Global L

SAN DIEGO, Feb. 24, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) today announced that the company will provide an overview of its technologies, development programs, and outlook at 2:15 p.m. PT on Thursday, March 2, at Biocom's Global Life Science Partnering Conference (La Jolla – March  1-2). A copy of the presentation will be available through the Events & Presentations page in the Investors section of the Vical website at www.vical.com .

About Vical Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on its patented DNA delivery technologies and other therapeutic approaches. Additional information on Vical is available at www.vical.com .

Contact: Tony Ramos (858) 646-1127 Website: www.vical.com